Compare Domino's Pizza, Inc. (DPZ) vs Hinge Health Inc. Class A Common Stock (HNGE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Domino's Pizza, Inc. vs Hinge Health Inc. Class A Common Stock — how do they compare? Domino's Pizza, Inc. trades at $298 (market cap $9.73B), while Hinge Health Inc. Class A Common Stock trades at $103.99 (market cap $8.47B). The key difference: Domino's Pizza, Inc. and Hinge Health Inc. Class A Common Stock are close in size by market cap, and Domino's Pizza, Inc. pays a 2.69% dividend while Hinge Health Inc. Class A Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Domino's Pizza, Inc. for 106 Days and Hinge Health Inc. Class A Common Stock for 0 Days on average.
| DPZ | HNGE | |
|---|---|---|
Market Cap | $9.73B | $8.47B |
Volume | 1,426,037 | 1,624,526 |
Sector | Consumer Cyclical | Health |
52-Week High | $438.42 | $105.14 |
52-Week Low | $282.89 | $31.17 |
Typical Hold Time | 106 Days | 0 Days |
Enterprise Value | $14.63B | $8.09B |
Dividend Yield | 2.69% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Domino's Pizza (DPZ) trades at $296.10, down 4.76% with recent earnings showing mixed results including a Q3 2026 beat. The stock maintains strong profitability with 12.03% net margin and trades at reasonable valuations (P/E 16.3, P/S 1.96). Technical indicators show a bullish overall signal despite near-term bearish pressure, with key support at $297. Recent news highlights dividend stability amid high debt levels and store closures in certain markets.
DPZ presents a compelling value opportunity with analyst consensus target of $361.44 (22% upside), though significant debt load and recent earnings misses warrant caution. The company's consistent revenue growth and strong cash flow generation support dividend sustainability, but competitive pressures and execution risks remain key watchpoints for investors.
Hinge Health (HNGE) trades at $105.14, up 0.31% on the day and near its 52-week high. The stock shows strong analyst support with a 93.75% buy rating, though the current price exceeds the consensus target of $101.62. Recent earnings beat expectations in two of the last three quarters, with Q3 2026 results due November 2. Fundamentals indicate robust revenue growth projections from $588 million in 2025 to $720 million in 2026, alongside a shift to profitability, but valuation multiples like EV/EBITDA at 82.33 remain elevated.
The outlook is cautiously optimistic given projected profitability and expansion into migraine and GI care, but risks include high insider selling, competitive pressures, and the stock's premium valuation. Execution on growth targets and Q3 earnings will be critical for sustaining momentum.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Domino's Pizza, Inc.
Domino's is a restaurant operator and franchiser with nearly 19,000 global stores across more than 90 international markets at the end of 2021. The firm generates revenue through the sales of pizza, wings, salads, and sandwiches at company-owned stores, royalty and marketing contributions from franchise-operated stores, and its network of 25 domestic (and five Canadian) dough manufacturing and supply chain facilities, which centralize purchasing, preparation, and last-mile delivery for the firm's U.S. and Canadian restaurants. With roughly $17.7 billion in 2021 system sales, Domino's is the largest player in the global pizza market, ahead of Pizza Hut, Papa John's, and Little Caesars.
Read more on DPZ →About Hinge Health Inc. Class A Common Stock
Hinge Health Inc. operates a digital musculoskeletal (MSK) care platform that delivers exercise therapy for joint and muscle conditions through health plans and employers. Its Precision Motion Technology combines wearable sensors and computer vision to guide patients through clinician-directed physical therapy remotely.
Read more on HNGE →
